GADGVGKSA
This synthetic GADGVGKSA peptide corresponds to the immunogenic neoantigen encoded by the KRAS G12D mutation. It is utilized in cancer immunotherapy research for in vitro T-cell activation assays and in vivo studies evaluating neoantigen-specific vaccine efficacy.
Product Specifications
Field of Research
Signal Transduction
Molecular Weight
760.79
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
